| Date Filed | Type | Description |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/28/2023 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 9,386 shares
@ $289.12, valued at
$2.7M
|
|
| 02/22/2023 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 9,359 shares
@ $292.85, valued at
$2.7M
|
|
| 02/14/2023 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,372 shares
@ $294.33, valued at
$992.5k
Paid exercise price by delivering 5,990 shares
@ $298.26, valued at
$1.8M
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 10,000 shares
@ $315.05, valued at
$3.2M
|
|
| 08/17/2022 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 11,689 shares
@ $305.06, valued at
$3.6M
|
|
| 07/21/2022 |
4/A
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,031 shares
@ $237.74, valued at
$720.6k
|
|
| 11/23/2021 |
4
| Kewalramani Reshma (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Granted 9,818 restricted stock units
@ $0 |
|
| 08/23/2021 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Bought 5,757 shares
@ $195.14, valued at
$1.1M
Bought 4,243 shares
@ $196.34, valued at
$833.1k
|
|
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2020 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 152 shares
@ $269.11, valued at
$40.9k
Sold 870 shares
@ $270.36, valued at
$235.2k
Sold 471 shares
@ $271.42, valued at
$127.8k
Sold 487 shares
@ $272.76, valued at
$132.8k
Sold 93 shares
@ $273.27, valued at
$25.4k
Exercised 1,564 options to buy
@ $187.53, valued at
$293.3k
Exercised 509 options to buy
@ $155.57, valued at
$79.2k
|
|
| 05/19/2020 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2 shares
@ $274.37, valued at
$548.7
Sold 6 shares
@ $276.4, valued at
$1.7k
Sold 7 shares
@ $279.7, valued at
$2k
Sold 9 shares
@ $280.47, valued at
$2.5k
Sold 6 shares
@ $281.74, valued at
$1.7k
Sold 4 shares
@ $282.74, valued at
$1.1k
Sold 10 shares
@ $283.76, valued at
$2.8k
Sold 27 shares
@ $286.07, valued at
$7.7k
Sold 19 shares
@ $287.63, valued at
$5.5k
Sold 9 shares
@ $288.37, valued at
$2.6k
|
|
| 05/08/2020 |
4
| Kewalramani Reshma (CEO & President) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 416 shares
@ $270.35, valued at
$112.5k
Sold 300 shares
@ $271.92, valued at
$81.6k
Sold 360 shares
@ $272.77, valued at
$98.2k
Sold 864 shares
@ $274.04, valued at
$236.8k
Sold 134 shares
@ $275.17, valued at
$36.9k
Exercised 1,564 options to buy
@ $187.53, valued at
$293.3k
Exercised 510 options to buy
@ $155.57, valued at
$79.3k
|
|
| 02/26/2020 |
4
| Kewalramani Reshma (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 2,898 shares
@ $239.23, valued at
$693.3k
Sold 893 shares
@ $229.72, valued at
$205.1k
Sold 450 shares
@ $230.88, valued at
$103.9k
Sold 440 shares
@ $232.35, valued at
$102.2k
Sold 660 shares
@ $234.41, valued at
$154.7k
Sold 340 shares
@ $235.36, valued at
$80k
Sold 320 shares
@ $236.71, valued at
$75.7k
Sold 420 shares
@ $238.28, valued at
$100.1k
Sold 111 shares
@ $239.13, valued at
$26.5k
|
|
| 02/19/2020 |
4
| Kewalramani Reshma (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 944 shares
@ $241.5, valued at
$228k
Sold 120 shares
@ $241.71, valued at
$29k
Sold 540 shares
@ $242.62, valued at
$131k
Sold 134 shares
@ $243.76, valued at
$32.7k
Sold 260 shares
@ $244.94, valued at
$63.7k
Sold 129 shares
@ $245.75, valued at
$31.7k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/26/2019 |
4
| Kewalramani Reshma (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 4,692 shares
@ $219.37, valued at
$1M
Exercised 4,692 options to buy
@ $187.53, valued at
$879.9k
|
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2019 |
4
| Kewalramani Reshma (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 241 shares
@ $165.41, valued at
$39.9k
|
|
|